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Introduction
Immunological aspects of strategies for xenotransplantation in 
humans are best modeled using old world monkeys or baboons 
as hosts. This is because the non-human primates share uniquely 
with humans a complex and redundant immune system that 
includes the capacity for humoral rejection of vascularized 
implants originating from pigs, a frequently used donor-species, 
outbred diversity and MHC expression patterns known to pres-
ent barriers to long-term graft survival.1 Research employing 
non-human primates is limited by its expense, and the paucity 
of facilities that can provide the highly specialized resources and 
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Transplantation therapy for diabetes is limited by 
unavailability of donor organs and outcomes complicated 
by immunosuppressive drug toxicity. Xenotransplantation 
is a strategy to overcome supply problems. Implantation of 
tissue obtained early during embryogenesis is a way to reduce 
transplant immunogenicity. Insulin-producing cells originating 
from embryonic pig pancreas obtained very early following 
pancreatic primordium formation [embryonic day 28 (E28)] 
engraft long-term in inbred diabetic Lewis or Zucker diabetic 
fatty (ZDF) rats or rhesus macaques. Endocrine cells originating 
from embryonic pig pancreas transplanted in host mesentery 
migrate to mesenteric lymph nodes, engraft, normalize 
glucose tolerance in rats and improve glucose tolerance in 
rhesus macaques without the need for immune suppression. 
Engraftment of primordia is permissive for engraftment of 
an insulin-expressing cell component from porcine islets 
implanted subsequently without immune suppression. 
Similarities between findings in inbred rat and non-human 
primate hosts bode well for successful translation to humans 
of what could be a novel xenotransplantation strategy for the 
treatment of diabetes.
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expertise required to meet the physical and emotional needs of 
these close human relatives. For this reason, inbred rodents, more 
widely available than non-human primates and less expensive to 
maintain, are commonly employed to generate data preliminary 
to non-human primate studies.2 Unfortunately, immunological 
differences between rodents and primates can result in an inabil-
ity to translate findings made in the former to members of the 
latter species. In addition, rats and mice housed in a laboratory 
setting are sedentary, obese and glucose intolerant. These fac-
tors may confound interpretation of data generated to ascertain 
whether one or another therapeutic intervention, successful in 
rats, will correct metabolic abnormalities such as those of diabe-
tes mellitus in humans.1,2
Diabetes is a common, disabling and deadly metabolic dis-
ease that has reached epidemic proportions worldwide.3,4 Among 
adults in the US, diabetes is the leading cause of new cases of 
blindness, kidney failure and amputations of feet and legs not 
related to accidents or injury. Transplantation therapy for diabe-
tes mellitus represents the best way to replace organ function in 
humans and the only way to prevent long-term complications. 
Unfortunately it is limited by unavailability of human donor 
organs and outcomes are complicated by immunosuppressive 
drug toxicity. There are approximately 1,000 pancreas and islet 
transplants performed per year in the USA, where the diabetic 
population exceeds 20 million individuals.5 Transplantation is 
rarely used for type 2 diabetes which is almost 20 times more 
common than type 1 disease.4,5 When performed, whole pan-
creas or islet transplantation requires use of potent immune sup-
pressive medications that have significant complications.1,4,5
Pig insulin works well in humans. For that reason, the pig 
could be a physiologically suitable β cell donor.1 The severity of 
humoral rejection effectively precludes the use of pigs, as whole 
pancreas donors. However, because they are vascularized by the 
host post-transplantation, pancreatic cellular transplants, that 
include embryonic pancreas and isolated islets, are not subject 
to humoral rejection.4 Experience with non-transgenic or trans-
genic pig to primate islet or neonatal islet transplantation in 
immune suppressed non-human primates shows that sustained 
insulin independence can be achieved, but only through the use 
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organs. Approximately a decade ago, we observed that embry-
onic pig kidney, transplanted across a wide xenogeneic barrier 
into immune-suppressed rodent (inbred mouse or rat) mesentery 
undergoes differentiation into an anatomically precise renal organ 
at the transplant site.9,10 When we attempted the same approach 
using embryonic pig pancreas rather than kidney, we discovered 
using two inbred rat strains as hosts [Lewis rats rendered diabetic 
using streptozotocin (STZ) 10-13 a model for type 1 diabetes in 
humans or ZDF rats,14 a model for type 2 diabetes] that unlike 
kidney, embryonic pancreas does not differentiate in situ into an 
anatomically precise pancreas. Rather, (1) pancreas differenti-
ates selectively in that only endocrine cells survive, (2) endocrine 
cells migrate into host mesenteric lymph nodes from where they 
release insulin in a glucose-regulated manner, (3) host immune 
suppression, required for engraftment of transplanted embryonic 
pig kidney into mice or rats is not required for engraftment of 
early-stage embryonic pancreas and (4) engraftment of embry-
onic pig pancreas permits engraftment of a cellular component 
originating from adult pig islets transplanted subsequently.
Employing protocols developed for embryonic-pig to STZ-
diabetic Lewis rat pancreas transplantation and recapitulated in 
ZDF rat hosts, we showed that embryonic pig pancreas engrafts, 
and improves glucose tolerance in STZ-diabetic rhesus macaques 
without the need for immune suppression.15,16 Here we review 
the successful adaptation of pig-into-diabetic rat transplantation 
technology to a pig-into-diabetic non-human primate model. 
Similarities of data generated in rat and non-human primate 
hosts suggest that, whatever the mechanism may be that per-
mits engraftment and function without an immune-suppression 
requirement, it will be applicable to diabetic humans and may 
translate into a novel xenotransplantation therapy.
Transplantation of Embryonic Pig Pancreas  
in Diabetic Rats and Rhesus Macaques
The importance of obtaining primordia from embryos in timed-
pregnant sows. Figure 1A illustrates a pancreas dissected from 
an embryonic day 28 (E28) Yorkshire pig embryo. The dorsal 
pancreas (dp) and ventral pancreas (vp) components originating 
from the duodenum (duo) are separate at this stage of embryonic 
development. An anti-insulin antibody-stained section of E28 
pig pancreas shows a relatively undifferentiated organ that con-
tains some insulin positive cells (Fig. 1B and arrow). Figure 1C 
is a negative control for which normal serum was substituted for 
the anti-insulin antibody containing serum used to generate data 
shown in Figure 1B.
We have shown using diabetic rats as hosts that E28 or E29 
pig pancreas engrafts successfully without the need for host 
immune suppression following transplantation in mesentery 
(Fig. 2). However, E35 pig pancreas undergoes rejection.10 While 
we have not determined whether E30-E34 pig pancreas has a fate 
similar to organs obtained on E35, we always use E28 pig pan-
creas as a source for transplantation because it engrafts predict-
ably. It follows that the importance of obtaining accurately and 
precisely-timed pregnant Yorkshire sows from which to obtain 
E28 embryos is critical to the success of experiments.
of agents that are not approved for human use or that result in 
a high level of morbidity and mortality.1,4,6-8 As reviewed previ-
ously in Organogenesis,6-8 the use of embryonic tissue (kidney or 
pancreas) for transplantation offers theoretical advantages rela-
tive to transplantation of either stem cells or adult differentiated 
Figure 1. (A) Photograph of a pancreatic primordium freshly dissected 
from an E28 pig embryo and (B and C) photomicrographs of sections 
originating from E28 primordia stained using anti-insulin antibodies 
(B) or control serum (C). dp, dorsal pancreas; vp, ventral pancreas; duo, 
duodenum. Arrow delineates insulin-positive cells (B). Scale bars 10 um 
(A) and 1 um (B and C).
Figure 2. Photographs of mesentery from a rat (A and B) or a rhesus 
macaque (C and D) several weeks following sham-transplantation (A) or 
transplantation of E28 pig pancreatic primordia (B) or immediately fol-
lowing the transplantation of an E28 pig pancreatic primordium (C,  
arrowhead) or several weeks following transplantation (D). Arrow, 
lymph node (D). Scale bar 1 cm (D). Reproduced with permission.11,15
© 2012 Landes Bioscience.
Do not distribute.
www.landesbioscience.com Organogenesis 43
diabetic rats (Fig. 5A) and nearly normalized in diabetic rhesus 
macaques (Fig. 5B) following transplantation of E28 pig pan-
creatic primordia.
No rat insulin can be detected following transplantation of 
E28 pig pancreatic primordia in diabetic rats (Fig. 6A). Rather 
porcine insulin circulates following glucose infusion (Fig. 6B 
and C). Interestingly, levels are higher in arterial (Fig. 6C) 
than in venous blood (Fig. 6B), consistent with secretion into 
mesenteric lymphatics and entry into the arterial circulation 
via the thoracic duct, left subclavian vein and aorta. While cir-
culating rat insulin can be distinguished from porcine insulin 
using an enzyme-linked immunosorbent assay (ELISA) no anti-
body can distinguish porcine from primate (or human) insulin. 
Accordingly we distinguished between the two in the circula-
tion of rhesus macaques using sequential high performance liq-
uid chromatography, immunoaffinity chromatography and mass 
spectrometry.15 No rhesus macaque insulin (< 0.1 ng/ml) can be 
detected post-transplantation of E28 pig pancreatic primordia in 
Transplantation between sheets of mesentery. Following 
incubation for 45 min in vitro of dissected E28 pig pancre-
atic primordia with selected growth factors and cytokines, we 
implant individual dorsal and ventral components, within a tun-
nel dissected between tissue planes of the mesentery in diabetic 
rat or non-human primate hosts. Figure 2A and B shows mesen-
tery from STZ-diabetic Lewis rats. Relative to an age-matched 
sham-transplanted diabetic control (Fig. 2A), the mesentery in 
transplanted rats is opalescent (Fig. 2B) reflecting an increased 
quantity of fat and proliferation of lymphatic vessels. Figure 2C 
shows the mesentery of a STZ-diabetic rhesus macaque at the 
time of transplantation. A primordium between sheets of mesen-
tery is delineated (arrowhead). Figure 2D shows the mesentery 
post-transplantation. As in rats, accumulation of fat and pro-
liferation of lymphatic vessels are observed in mesentery post-
transplantation in non-human primates. A large lymph node is 
delineated in Figure 2D (arrow).
Engraftment in Mesenteric Lymph Nodes  
and Tissues along a Lymphatic Distribution
Shown in Figure 3A–D, are tissue sections of mesenteric lymph 
nodes from a STZ-diabetic Lewis rat into which E28 pig pan-
creatic primordia had been transplanted previously in mesentery 
stained using anti-insulin antibody (Fig. 3A and C), or control 
antiserum (Fig. 3B and D). Insulin positive cells are located 
predominantly in medullary sinus. Individual cells are evident 
in Figure 3C that do not stain in sections stained using con-
trol antiserum (Fig. 3D). Figure 3E–H show photomicrographs 
originating from a mesenteric lymph node of a STZ-diabetic 
rhesus macaque previously transplanted with E28 pig pancreatic 
primordia in mesentery. Sections E and G are stained with an 
anti-insulin antibody. Sections F and H are incubated with con-
trol serum. Individual cells with β cell morphology that stain 
positive (red) are delineated by arrows. No positive-staining cells 
are found in sections treated with control serum.
Engraftment of pig tissue in the mesenteric lymph nodes of 
Lewis rats and primates as shown using immune histochemistry 
(Fig. 3) is documented using in situ hybridization for porcine 
proinsulin mRNA. Shown in Figure 4 are tissue sections from a 
diabetic rat (Fig. 4A and B) or rhesus macaque (Fig. 4C and D) 
into which E28 pig pancreatic primordia had been transplanted 
previously. Cells expressing porcine mRNA stain with use of an 
antisense probe to porcine proinsulin mRNA (Fig. 4B and D), 
but not a sense probe (Fig. 4A and C).
Normalization or Improvement  
of Glucose Intolerance Following Transplantation  
of E28 Pig Pancreatic Primordia
Figure 5 shows the results of intravenous glucose tolerance test-
ing in Lewis rats (Fig. 5A) or rhesus macaques (Fig. 5B) prior 
to administration of STZ (Pre-STZ) and in the same animals 
following induction of STZ-diabetes (Post-STZ) and after 
transplantation of E28 pig pancreatic primordia (Post TX). 
Glucose tolerance is normalized in nonimmune-suppressed 
Figure 3. Photomicrographs of mesenteric lymph nodes from a 
STZ-diabetic Lewis rat (A–D) or STZ diabetic rhesus macaque (E–H) 
post-transplantation of E28 pig pancreatic primordia. Sections (A, C, E 
and G) are stained with an anti-insulin antibody. Sections (B, D, F and H) 
are stained using a control serum. Arrows (C and G) insulin positive cells. 
Scale bars 80 um (A and B); 30 um (C and D); 120 um (E and F) and 20 um 
(G and H). Reproduced with permission.13,15
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diabetic rhesus macaques. Rather, porcine insulin is detectable in 
plasma (Fig. 6D).
The ZDF rat is an inbred strain derived from a colony of 
Zucker fatty rats. ZDF and Zucker fatty animals have an autoso-
mal recessive mutation in the gene that encodes the leptin recep-
tor. Homozygous Zucker fatty rats manifest hyperphagia, obesity 
and severe insulin resistance, but are generally normoglycemic. 
ZDF homozygous males become hyperglycemic beginning 
at approximately 7 weeks of age and thereafter spontaneously 
develop overt diabetes. Homozygous females become overtly dia-
betic beginning at age 6–8 weeks only if maintained on a diabe-
togenic high fat diet. In ZDF males and females, hyperglycemia 
occurs concomitant with markedly elevated levels of circulating 
insulin and failure of insulin secretion in response to a glucose 
challenge, mimicking the pathophysiology of human type 2 dia-
betes mellitus.
Glucose intolerance is corrected in both male and female ZDF 
rats following transplantation of E28 pig pancreatic primordia in 
mesentery. Figure 7A shows the results of oral glucose tolerance 
testing in diabetic male ZDF rats prior to (Diabetic) and follow-
ing transplantation (Transplant). Levels of porcine insulin in the 
venous circulation following an oral glucose load are shown in 
Figure 7B. Levels of glucose (markedly elevated in diabetic ZDF 
rats) do not fall after intravenous administration of exogenous 
insulin to male ZDF rats reflecting insulin resistance. In contrast 
normalized glucose levels fall after intravenous insulin is injected 
in transplanted male ZDF rats, consistent with restored insulin 
sensitivity (Fig. 7C). To show that pig β cells within transplanted 
diabetic ZDF rats are capable of releasing insulin in response to 
glucose, we incubated mesenteric lymph nodes from rats into 
which pig pancreatic primordia in a solution containing 3 mM 
glucose. We took aliquots immediately prior to (time 0) and fol-
lowing addition of glucose to incubations so as render the glucose 
concentration 20 mM. As illustrated in Figure 7D no porcine 
insulin could be detected at time 0. However, porcine insulin was 
detectable by 1 min after increasing the glucose level, consistent 
with a first phase insulin release characteristic of β cells.
Whereas rats the glucose tolerance of which is normalized 
following transplantation of 5–8 E28 pig pancreatic primordia 
are rendered insulin independent for the remainder of their lives, 
macaques transplanted with 20–40 primordia remain dependent 
on exogenous insulin (albeit as doses lower than required prior to 
transplantation) to maintain euglycemia.15 The most likely expla-
nation for the differential success between rats and macaques is 
that macaques weigh 20 times as much as rats. A STZ-diabetic 
rat can be rendered normoglycemic lifelong with no exogenous 
insulin requirement by transplantation of 5–8 pig pancreatic pri-
mordia. Extrapolating, it would take 100–200 primordia to ren-
der a diabetic macaque independent of exogenous insulin. This 
would require the sacrifice of about 10–20 pregnant sows and 
multiple surgeries with the attendant complications.8
In lieu of increasing the numbers of transplanted primordia 
or transplant surgeries in diabetic rhesus macaques, we embarked 
on a series of experiments to determine whether porcine islets, a 
more easily obtainable and possibly more robust source of insu-
lin-producing cells, could be substituted for animals in which 
Figure 4. In situ hybridization was performed using pig proinsulin 
sense (A and C) or antisense probes (B and D) on sections of mesenteric 
lymph node originating from a STZ-diabetic Lewis rat (A and B) or a STZ-
diabetic rhesus macaque (C and D). Arrows delineate cells to which the 
antisense probe is hybridized (B and D). Scale bar 30 um. Reproduced 
with permission.12,15
Figure 5. Intravenous glucose tolerance in: (A) Lewis rats (n = 4); or 
(B) rhesus macaques (n = 3). Glucose in peripheral venous blood was 
measured prior to intravenous infusion of dextrose (Time 0) and at 
several times after infusion, in animals prior to administration of STZ 
(Pre-STZ); 5 d following administration of STZ (Post STZ); or following 
transplantation of: (A) 5–8; or (B) 20–40 E28 pig pancreatic primordia in 
mesentery (Post-TX). Data are shown as mean ± SE. Reproduced with 
permission.13,16
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not sense probes and cell nuclei hybridize to a probe for the por-
cine X chromosomes.13,16 Neither cells that stain for insulin nor 
cells to which a the probe for porcine proinsulin mRNA binds are 
present in contralateral (non-implanted) kidneys of STZ diabetic 
rats or macaques in which E28 pig pancreatic primordia were 
transplanted previously in mesentery, or in kidneys from STZ-
diabetic rats or macaques into which porcine islets are implanted 
without prior transplantation of E28 pig pancreatic primordia in 
mesentery.
Cells from porcine islets do not survive post-implantation in 
rat or macaque kidneys without prior transplantation of E28 pig 
pancreatic primordia transplantation in mesentery. Whole por-
cine islets do not engraft in kidneys. Rather, an endocrine (β cell) 
component originating from porcine islets does so.13,16 Ours is the 
first report describing sustained survival of such cells following 
transplantation of porcine islets in non-immune suppressed pri-
mates.16 Glucose tolerance in diabetic rats not fully-normalized 
by prior transplantation of E28 pig pancreatic primordia in mes-
entery, is corrected following subsequent implantation of porcine 
islets in kidney.13 In contrast, correction is not observed following 
E28 pig pancreatic primordia transplantation and porcine islets 
implantation in macaques, consistent with previous observations 
that glucose tolerance is more difficult to correct in macaques 
than in rats.8 It may be that the mass of engrafted cells origi-
nating from porcine islets implanted in kidney (perhaps derived 
from a numerically small stem cell component within the islets) 
is insufficient to impact on control of circulating glucose in an 
animal as large as a macaque.
embryonic pig pancreas already had engrafted. To this end, we 
implanted adult porcine islets beneath the capsule of one kidney 
from STZ-diabetic Lewis rats or macaques that several weeks 
earlier had been transplanted with E28 pig pancreatic primordia 
in mesentery.13,16 We employed the renal subcapsular site for islet 
implantation so that we could differentiate engrafted porcine tis-
sue originating from the islets from tissue originating from prior 
mesenteric E28 pig pancreatic transplants, that never engraft in 
host kidney. In this setting, the contralateral (non-transplanted) 
kidney served as a control as did kidneys from rats or macaques 
implanted with islets without prior transplantation of E28 pig 
pancreatic primordia in mesentery. As in experiments demon-
strating engraftment of cells originating from E28 pig pancre-
atic primordia transplanted in mesentery of rats or macaques, we 
employed multiple techniques to ascertain whether cells from 
porcine islets engraft in kidney including immune histochem-
istry for insulin, in situ hybridization specific for porcine pro-
insulin mRNA, and fluorescent in situ hybridization for pig X 
chromosomes.
Figure 8 shows sections from a kidney of a STZ-diabetic rat 
(Fig. 8A and B) or rhesus macaque (Fig. 8C and D) implanted 
with porcine islets following transplantation of E28 pig pan-
creatic primordia in mesentery. Sections are stained using anti-
insulin antibodies (Fig. 8A and C) or control serum (Fig. 8B 
and D). Cells that stain for insulin (Fig. 8A and C), but not 
with control serum (Fig. 8B and D) are present in an expanded 
renal subcapsular space. Nuclei of cells in the subcapsular space 
hybridize to antisense robes for porcine proinsulin mRNA, but 
Figure 6. (A–C) Levels of insulin in transplanted STZ diabetic Lewis rats (n = 4) measured during intravenous glucose tolerance testing. Data are 
shown and mean ± SE. (D) Left: Chromatogram (top) and product ion mass spectrum (bottom) of porcine insulin (precursor ion [M + 5H]5+ m/z 1156.3) 
extracted from 2 ml plasma obtained 5 min after IV glucose administration to a STZ-diabetic transplanted rhesus macaque. The retention time and 
diagnostic product ions derived from the 5-fold charged precursor ion unambiguously identify porcine insulin. (D) Right: chromatogram (top) and 
product ion mass spectrum (bottom) of human/macaque insulin (precursor ion [M + 5H]5+ m/z 1162.3) extracted from 1 ml of non-diabetic rhesus 
macaque plasma. The retention time and diagnostic product ions derived from the 5-fold charged precursor ion unambiguously identify human/ma-
caque insulin. Reproduced with permission.13,15
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their ability to induce revascularization by host endothelium, and 
their reduced immunogenicity, suggest that porcine embryonic 
xenotransplantation could offer an attractive replacement ther-
apy for diabetes.17
Host immune suppression was required for successful engraft-
ment of embryonic pig pancreas in rodents18 or non-human pri-
mates17 in the studies of Tchorsh-Yutsis et al. and Hecht et al. It 
is likely that one or more factors in the methodology we employ 
different from that used by these investigators17,18 is critical for 
engraftment without an immune suppression requirement. We 
have speculated regarding what the factors might be.19 First, the 
developmental stage of donor pig embryos from which primor-
dia are obtained impacts on the host immune response. We have 
shown that E35 pig pancreatic primordia are rejected in Lewis 
rats following transplantation employing conditions under which 
E28 or E29 pig pancreatic primordia engraft.10 While we have no 
experience transplanting E42 pig pancreatic primordia in rats, 
the preferred stage for studies described by Tchorsh-Yutsis et al. 
and Hecht et al. we would expect them to reject in the absence 
of host immune-suppression based on our experience with E35 
pancreatic primordia. Second, it is likely that that the incubation 
of embryonic pancreas with one or more growth factors and cyto-
kines we employ prior to transplantation alters the host immune 
response. Tchorsh-Yutsis et al. and Hecht et al. do not employ such 
agents. Third, the transplantation site and technique probably 
Perspectives
The studies reviewed above represent one of two independent 
decade-long efforts (ours based at Washington University6-8 
and the other at the Weizmann Institute of Science, Rehovot 
Israel17,18) to adapt xenotransplantation of embryonic pig pan-
creas as a novel therapy for diabetes mellitus in humans. Hecht 
et al.17 (Weizmann Institute) applied findings generated in mice 
(Tchorsh-Yutsis et al.)18 to a non-human primate model. The 
mouse studies had demonstrated the curative potential of such 
implants in diabetic mice under relatively tolerable immune sup-
pression. A working hypothesis, suggesting that embryonic pig 
pancreas transplantation would not be adversely affected by a 
humoral response was based on two observations: (1) hyperacute 
and acute rejection are mainly mediated by complement activa-
tion in blood vessels, mediated by preformed anti-pig antibod-
ies recognizing carbohydrates expressed on endothelial cells; and 
(2) data from the mouse studies showed that the embryonic pan-
creas implants predominantly induce host-type vasculature to 
support their growth and development in the recipient, resulting 
in an organ comprised mainly of porcine epithelial cells and host 
endothelium. It was found that that porcine E42 embryonic pan-
creatic tissue can correct hyperglycemia in diabetic Cynomolgous 
monkeys under a tolerable immune suppression protocol and 
concluded that long-term proliferative capacity of these grafts, 
Figure 7. (A) Levels of glucose (mg/dl) measured over 180 min after an oral glucose load in male ZDF rats (n = 4) prior to transplantation of E28 pig 
pancreatic primordia (diabetic) or following transplantation (Transplant); (B) levels of porcine insulin (ng/ml) measured over 120 min after an oral glu-
cose load in transplanted ZDF rats (n = 4). (C) Levels of glucose (mg/dl) measured over 120 min after i.v. insulin was administered to ZDF rats (n = 4);  
(D) levels of porcine insulin (ng/ml/g tissue wet weight) measured over 60 min in a solution containing mesenteric lymph node tissue from diabetic 
ZDF rats into which pig pancreatic primordia had been transplanted previously (n = 4). Immediately after measurements were made at time 0, glucose 
was added so as to increase the concentration from 3 mM o 20 mM, a range over which insulin secretion is stimulated in vivo. Data are expressed as 
mean ± SE. Reproduced with permission.14
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impact on the host immune response. We interpose pancreatic 
primordia between sheets of mesentery. Tchorsh-Yutsis et al. and 
Hecht et al. transplant into pockets of omentum and secure using 
suture. The omentum “pocket” or “pouch” transplantation site 
was developed for transplantation of syngeneic islets into rats20 
and adapted for transplantation of allogenetic islets into non-
human primates21 the omental anatomy of which is comparable 
to that of humans.22
The potential for use of the mesenteric transplant site to 
enable dissemination of cells along a lymphatic distribution and 
engraftment in mesenteric lymph nodes was confirmed recently 
in fumarylacetoacetate mice (Fah-/-), a model for the human liver 
disease tyrosinemia type I. Intra peritoneal transplantation of 
liver cells from congenic wild-type mice resulted in correction 
of metabolic abnormalities and long-term survival of the animals 
that otherwise would have died. Transplantation of liver cells 
into the peritoneal cavity allowed the hepatocytes to migrate into 
the lymphatic system, enter mesenteric lymph nodes and expand 
under homeostatic mechanisms driven by the liver. When ecto-
pic liver tissue reached the required balance for hepatic function, 
proliferation ceased resulting in 20 to 40 “hepatized” mesenteric 
lymph nodes that represented 70% of the original liver mass. 
The authors speculate that the highly vascularized nature of 
the lymph nodes supports the efficient engraftment and massive 
expansion of ectopic tissue and can be compared with a well-
designed in vivo bioreactor.23 Little is known about the factors 
that regulate the differentiation, migration and immunogenicity 
of cells transplanted within mesentery. Delineation of such fac-
tors could enable optimization of engraftment and expansion of 
endocrine cells originating from E28 pig pancreatic primordia 
distributed similarly via the lymphatic route.
Figure 8. Sections of the islet-implanted kidney from a STZ-diabetic 
Lewis rat (A and B) or rhesus macaque (C and D) transplanted with E28 
pig pancreatic primordia in mesentery followed by porcine islets in the 
renal subcapsular space stained using anti-insulin antibodies (A and C) 
or control antiserum (B and D). PT, proximal tubule. RC, renal capsule. 
Arrows, positively staining cells (A and C); negatively staining cells (B 
and D). Scale bar 10 um. Reproduced with permission.13,16
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